about
sameAs
Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: an experimental murine model.Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureusHeterogeneity within and across Pediatric Pulmonary Infections: From Bipartite Networks to At-Risk SubphenotypesMAVS and MyD88 are essential for innate immunity but not cytotoxic T lymphocyte response against respiratory syncytial virusHost immune transcriptional profiles reflect the variability in clinical disease manifestations in patients with Staphylococcus aureus infectionsRespiratory viruses identified in an urban children's hospital emergency department during the 2009 influenza A(H1N1) pandemic.Whole blood gene expression profiles to assess pathogenesis and disease severity in infants with respiratory syncytial virus infection.The association between respiratory syncytial virus infection and the development of childhood asthma: a systematic review of the literature.Persistence of herpes simplex virus DNA in cerebrospinal fluid of neonates with herpes simplex virus encephalitis.Enhanced monocyte response and decreased central memory T cells in children with invasive Staphylococcus aureus infectionsInfliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease.Differences in antibody responses between trivalent inactivated influenza vaccine and live attenuated influenza vaccine correlate with the kinetics and magnitude of interferon signaling in children.Microbiologic and immunologic evaluation of a single high dose of azithromycin for treatment of experimental Mycoplasma pneumoniae pneumoniaDetecting specific infections in children through host responses: a paradigm shiftEvaluation of LBM415 (NVP PDF-713), a novel peptide deformylase inhibitor, for treatment of experimental Mycoplasma pneumoniae pneumoniaConcomitant respiratory viral infections in children with Kawasaki disease.Predictors for successful treatment of pediatric deep neck infections using antimicrobials alone.Comparative effects of two neutralizing anti-respiratory syncytial virus (RSV) monoclonal antibodies in the RSV murine model: time versus potency.Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection.Gene expression patterns in blood leukocytes discriminate patients with acute infections.RNA transcriptional biosignature analysis for identifying febrile infants with serious bacterial infections in the emergency department: a feasibility study.Human metapneumovirus: a not so new virus.Plasticity and virus specificity of the airway epithelial cell immune response during respiratory virus infection.Respiratory syncytial virus: old challenges and new approaches.Superiority of transcriptional profiling over procalcitonin for distinguishing bacterial from viral lower respiratory tract infections in hospitalized adults.Respiratory syncytial virus pneumonia: mechanisms of inflammation and prolonged airway hyperresponsiveness.Enterovirus D68 in Hospitalized Children: Sequence Variation, Viral Loads and Clinical OutcomesBlood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade.Respiratory syncytial virus infections: old challenges and new opportunities.Motavizumab, a neutralizing anti-Respiratory Syncytial Virus (Rsv) monoclonal antibody significantly modifies the local and systemic cytokine responses induced by Rsv in the mouse modelInnate immune dysfunction is associated with enhanced disease severity in infants with severe respiratory syncytial virus bronchiolitis.Induction of ICOS+CXCR3+CXCR5+ TH cells correlates with antibody responses to influenza vaccinationRhinovirus Detection in Symptomatic and Asymptomatic Children: Value of Host Transcriptome Analysis.The impact of steroids given with macrolide therapy on experimental Mycoplasma pneumoniae respiratory infection.Respiratory syncytial virus persistence in the lungs correlates with airway hyperreactivity in the mouse model.Interferon-driven alterations of the host's amino acid metabolism in the pathogenesis of typhoid fever.Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.Daptomycin therapy for invasive Gram-positive bacterial infections in children.Human adenovirus infection in Kawasaki disease: a confounding bystander?Risk factors in children hospitalized with RSV bronchiolitis versus non-RSV bronchiolitis.
P50
Q24811196-4F7DCAF4-4ADC-4843-A2DD-CFC5DC2D981FQ28244050-FB5CA4C8-C242-4692-A13E-AA1485B1A4E5Q28388098-17A95547-B874-4B20-8D7A-C14E04670ADCQ28593715-AB9C708E-662E-497F-8F82-962C097F81CAQ28730753-326667C8-49BC-491F-9E16-96E6E4E17A32Q30421772-49357545-7304-46EA-B4AA-A67D45A058D4Q31144301-5F2A6CFB-1270-4946-B66D-3324CAB65ABBQ33298578-15B2D0BB-1175-4665-A819-D2CE9C4CE106Q33405731-B5C629EC-5BCD-4A33-BFBD-59029C8C7283Q33441384-8FD914F7-C863-475F-ADCE-1944DDFF00F5Q33798966-269E7590-4CD5-40B8-A007-D5280F74D941Q33883224-8D337986-FBAB-45A4-BED5-3C48B8C919F8Q33935311-D7C3E170-E238-45EB-92A4-D7B9C88AEB77Q34064005-74CE6148-6F0B-4293-BF23-F97DD301FA3BQ34077056-4121F4E7-55AB-41DE-B18D-8162E837F7C4Q34081277-C2B7E812-F505-47CB-85B0-1ADA945F852CQ34118073-6F58D1F1-081E-4217-AEA8-42E0D4807A0DQ34123608-DF0F2129-6805-425A-B5BF-5744D756A663Q34335695-BEE74C61-4B61-4CD1-AB36-2F266F354183Q34581696-19AF5547-CD25-45A3-9118-D5A8F3902C3BQ34990685-89A742EA-923B-47F4-BC74-A3B8784B5CD8Q35638311-D73F7CF9-D324-4669-87B3-F3F7EA307FB4Q35943423-91DC9464-84D6-4382-8D8C-66E9220A1E89Q36031115-0F293221-0195-480A-AD7B-612908496322Q36049031-A794BE26-559A-483E-BBCD-50EFC49D8116Q36111797-57345115-A937-489E-B655-405D7055FD98Q36201238-68085605-B94B-4FE2-848E-36DB32C24B57Q36229664-7BDD12D0-2DC9-4F5E-8D7A-8F696D6E5A71Q36353673-DC22174F-2F8D-4B40-ADE7-E6BA87C7D9ADQ36419843-CFAA3A6B-DF52-4903-A103-5564DCB4F340Q36727270-C692D0D3-EC08-4E6F-BB8B-21C624F97D34Q36752092-8372C93E-270E-482C-B0A4-68698A330EDBQ36778560-3E122382-53EB-487A-A947-E494604D9402Q36924030-A1D85593-17D4-4B0C-B52E-0B84E0BE49D3Q36946801-EF09B942-C602-4D47-B4B0-E9773FF17B19Q36949893-93BBF88F-E4F1-4DC1-8C15-0B2F12565421Q37016967-5737646F-0480-44D1-B5F8-9735BD4D36B2Q37016970-5A60E5ED-79E2-471F-BFF9-54FD49E8C997Q37066086-A265FC3C-767F-4EEC-B945-FB9B22EC42E5Q37144043-54651B40-880E-4198-9D93-3094A7348BC9
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Asuncion Mejias
@ast
Asuncion Mejias
@en
Asuncion Mejias
@es
Asuncion Mejias
@fr
Asuncion Mejias
@nl
type
label
Asuncion Mejias
@ast
Asuncion Mejias
@en
Asuncion Mejias
@es
Asuncion Mejias
@fr
Asuncion Mejias
@nl
altLabel
Asuncion Mejías
@en
Asuncion Mejías
@fr
Mejías A
@en
prefLabel
Asuncion Mejias
@ast
Asuncion Mejias
@en
Asuncion Mejias
@es
Asuncion Mejias
@fr
Asuncion Mejias
@nl
P106
P21
P214
164146284411315332225
P31
P496
0000-0002-5983-8006